EN
HI
Summary
As of 22 Sep, 2026, Emcure Pharmaceuticals stock price is ₹2001.1. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Emcure Pharmaceuticals has traded between ₹1260.00 and ₹2100.70.
The stock has recorded a trading volume of 526 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹2001.10.
Emcure Pharmaceuticals has an upper circuit limit of ₹2210.20 and a lower circuit limit of ₹1808.40. The total value traded stands at ₹0.00, and the delivery percentage for the day is 33.38%.
The stock is currently traded with a market lot size of 1. Emcure Pharmaceuticals also offers a dividend yield of 0.18%.
Emcure Pharmaceuticals Share Price Chart
Emcure Pharmaceuticals Share Key Metrics
Volume
526.00
Market Cap
38108.29 CR
LTQ@LTP
1@2001.10
ATP
0
Var Margin
16.45 %
Circuit Range
1808.4-2210.2
Delivery %
33.38 %
Value
0.00
ASM/GSM
No
Market Lot
1
Emcure Pharmaceuticals Fundamentals
P/E Ratio
37.53
P/B Ratio
7.26
Div. Yield
0.18
Sector P/E
37.95
Sector P/B
3.67
Sec. Div. Yield
0.51
Emcure Pharmaceuticals Resistance and Support
Pivot 2017.1
Resistance
First Resistance
2037.2
Second Resistance
2065.1
Third Resistance
2085.2
Support
First Support
1989.2
Second Support
1969.1
Third Support
1941.2
Emcure Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Sep 21 2026 | 2045 | 2009.3 | 0.27% | 2045 | 1997 |
| Fri Sep 18 2026 | 1915.9 | 2003.8 | 4.92% | 2100.69 | 1915.09 |
| Thu Sep 17 2026 | 1913.19 | 1909.8 | -1.14% | 1940.4 | 1891.59 |
Emcure Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-05 | Audited Results & Final Dividend |
| 2026-02-04 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-06 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Emcure Pharmaceuticals News
Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Credit Rating
CARE Ratings Limited reaffirmed Emcure Pharmaceuticals' long-term bank facilities rating at CARE AA; Stable and short-term facilities at CARE A1+. This reaffirmation reflects the company's healthy business risk profile and improved operating profitability in FY26.
Sep 01 2026 15:44:17
Emcure Pharmaceuticals Management
| Name | Position |
|---|---|
| Berjis Desai | Chairman |
| Satish Mehta | Managing Director & Chief Executive Officer |
Emcure Pharmaceuticals Similar Stocks
Glaxosmithkline Pharmaceuticals Ltd.
2870.00
7.10 (0.25%)
Ajanta Pharma Ltd.
3521.20
-20.90 (0.59%)
Global Health Ltd.
1504.90
-3.20 (0.21%)
Narayana Hrudayalaya Ltd.
1905.00
8.10 (0.43%)
Krishna Institute of Medical Sciences Ltd
789.55
0.70 (0.09%)
Sai Life Sciences Ltd.
1604.00
-4.00 (0.25%)
Wockhardt Ltd.
2187.00
-0.30 (0.01%)
Dr. Lal Pathlabs Ltd.
1902.30
-18.10 (0.94%)
Neuland Laboratories Ltd.
22690.00
80.00 (0.35%)
Emcure Pharmaceuticals FAQs
The Buying Price of Emcure Pharmaceuticals share is 2001.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Emcure Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Emcure Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Emcure Pharmaceuticals shares is 37.53. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Emcure Pharmaceuticals shares is 7.26. Useful to assess the stock's value relative to its book value.
To assess Emcure Pharmaceuticals’s valuation compare Sector P/E, P/B which are 37.95 & 3.67 with sector averages, along with growth rates and financial metrics.
The Market Cap of Emcure Pharmaceuticals is 38108.29 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Emcure Pharmaceuticals share price is 2100.70 & 1260.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Emcure Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in EMCURE
